Avance Clinical Trials
Trial – AMGEN/IQVIA Suffering from Chronic Hives? A 32-week Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging, Phase 2b Study to Evaluate Efficacy and Safety of xxxxxxxxxx for
Trial – Sun Pharma | IQVIA A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Assess the Efficacy and Safety of XXXXXXXXX in the Treatment of
Trial – Amgen | PPD A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Apremilast (CC-10004) in Pediatric Subjects from
This ICON/Trevi 1 year study aims to determine the evaluate the safety, tolerability, and effectiveness of nalbuphine as a treatment for the itching related to
Trial – Syneos Health/Eli Lilly Eli Lilly and Company are conducting a study on an investigational drug called XXXXXXXXX as a possible treatment for moderate-to-severe
Phase III Clinical Trial – Novartis A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up to 1 year), safety, and tolerability
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.